Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 09 10 2022
accepted: 21 04 2023
revised: 29 03 2023
medline: 27 11 2023
pubmed: 4 7 2023
entrez: 4 7 2023
Statut: ppublish

Résumé

To validate the proton density fat fraction (PDFF) obtained by the MRQuantif software from 2D chemical shift encoded MR (CSE-MR) data in comparison with the histological steatosis data. This study, pooling data from 3 prospective studies spread over time between January 2007 and July 2020, analyzed 445 patients who underwent 2D CSE-MR and liver biopsy. MR derived liver iron concentration (MR-LIC) and PDFF was calculated using the MRQuantif software. The histological standard steatosis score (SS) served as reference. In order to get a value more comparable to PDFF, histomorphometry fat fraction (HFF) were centrally determined for 281 patients. Spearman correlation and the Bland and Altman method were used for comparison. Strong correlations were found between PDFF and SS (r The PDFF obtained by MRQuantif from a 2D CSE-MR sequence is highly correlated with the steatosis score and very close to the fat fraction estimated by histomorphometry. Liver iron overload reduced the performance of steatosis quantification and joint quantification is recommended. This device-independent method can be particularly useful for multicenter studies. The quantification of liver steatosis using a vendor-neutral 2D chemical-shift MR sequence, processed by MRQuantif, is well correlated to steatosis score and histomorphometric fat fraction obtained from biopsy, whatever the magnetic field and the MR device used. • The PDFF measured by MRQuantif from 2D CSE-MR sequence data is highly correlated to hepatic steatosis. • Steatosis quantification performance is reduced in case of significant hepatic iron overload. • This vendor-neutral method may allow consistent estimation of PDFF in multicenter studies.

Identifiants

pubmed: 37402003
doi: 10.1007/s00330-023-09798-4
pii: 10.1007/s00330-023-09798-4
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8999-9009

Informations de copyright

© 2023. The Author(s), under exclusive licence to European Society of Radiology.

Références

Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28:155–161. https://doi.org/10.1159/000282080
doi: 10.1159/000282080 pubmed: 20460905
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84. https://doi.org/10.1002/hep.28431
doi: 10.1002/hep.28431 pubmed: 26707365
Tapper EB, Lok AS-F (2017) Use of liver imaging and biopsy in clinical practice. N Engl J Med 377:756–768. https://doi.org/10.1056/NEJMra1610570
doi: 10.1056/NEJMra1610570 pubmed: 28834467
Rockey DC, Caldwell SH, Goodman ZD et al (2009) Liver biopsy Hepatol Baltim Md 49:1017–1044. https://doi.org/10.1002/hep.22742
doi: 10.1002/hep.22742
Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol Baltim Md 41:1313–1321. https://doi.org/10.1002/hep.20701
doi: 10.1002/hep.20701
Hussain HK, Chenevert TL, Londy FJ et al (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display–early experience. Radiology 237:1048–1055. https://doi.org/10.1148/radiol.2373041639
doi: 10.1148/radiol.2373041639 pubmed: 16237138
Li M, Song J, Mirkov S, Xiao SY, Hart J, Liu W (2011) Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. Hum Pathol 42:356–360. https://doi.org/10.1016/j.humpath.2010.07.013
doi: 10.1016/j.humpath.2010.07.013 pubmed: 21111448
Boursier J, Chaigneau J, Roullier V et al (2011) Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. Eur J Gastroenterol Hepatol 23:974–981. https://doi.org/10.1097/MEG.0b013e32834a4d82
doi: 10.1097/MEG.0b013e32834a4d82 pubmed: 21904208
Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97. https://doi.org/10.1007/s00330-010-1905-5
doi: 10.1007/s00330-010-1905-5 pubmed: 20680289
Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-468. https://doi.org/10.1152/ajpendo.00064.2004
doi: 10.1152/ajpendo.00064.2004 pubmed: 15339742
Reeder SB, Sirlin CB (2010) Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 18(337–357):ix. https://doi.org/10.1016/j.mric.2010.08.013
doi: 10.1016/j.mric.2010.08.013 pubmed: 21094445
Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characterization of the liver fat
doi: 10.1002/nbm.1622 pubmed: 21834002
Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749–759. https://doi.org/10.1148/radiol.10100659
doi: 10.1148/radiol.10100659 pubmed: 21212366 pmcid: 3042639
Yu H, Shimakawa A, McKenzie CA et al (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60:1122–1134. https://doi.org/10.1002/mrm.21737
doi: 10.1002/mrm.21737 pubmed: 18956464 pmcid: 3070175
Reeder SB, Robson PM, Yu H et al (2009) Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 29:1332–1339. https://doi.org/10.1002/jmri.21751
doi: 10.1002/jmri.21751 pubmed: 19472390 pmcid: 2689318
Yokoo T, Bydder M, Hamilton G et al (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67–76. https://doi.org/10.1148/radiol.2511080666
doi: 10.1148/radiol.2511080666 pubmed: 19221054 pmcid: 2663579
Heba ER, Desai A, Zand KA et al (2016) Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging 43:398–406. https://doi.org/10.1002/jmri.25006
doi: 10.1002/jmri.25006 pubmed: 26201284
Zand KA, Shah A, Heba E et al (2015) Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. J Magn Reson Imaging 42:1223–1232. https://doi.org/10.1002/jmri.24888
doi: 10.1002/jmri.24888 pubmed: 25847512 pmcid: 4592685
Gu J, Liu S, Du S et al (2019) Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol 29:3564–3573. https://doi.org/10.1007/s00330-019-06072-4
doi: 10.1007/s00330-019-06072-4 pubmed: 30899974
Qu Y, Li M, Hamilton G et al (2019) Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis. Eur Radiol 29:5180–5189. https://doi.org/10.1007/s00330-019-06071-5
doi: 10.1007/s00330-019-06071-5 pubmed: 30877459
Gu Q, Cen L, Lai J et al (2021) A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. Eur J Clin Invest 51:e13446 https://doi.org/10.1111/eci.13446
doi: 10.1111/eci.13446 pubmed: 33128454
Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486–498. https://doi.org/10.1148/radiol.2017170550
doi: 10.1148/radiol.2017170550 pubmed: 28892458
Hu HH, Yokoo T, Bashir MR et al (2021) Linearity and bias of proton density fat fraction as a quantitative imaging biomarker: a multicenter, multiplatform, multivendor phantom study. Radiology 298:640–651. https://doi.org/10.1148/radiol.2021202912
doi: 10.1148/radiol.2021202912 pubmed: 33464181
Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425. https://doi.org/10.1148/radiol.14140754
doi: 10.1148/radiol.14140754 pubmed: 25247408
Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775. https://doi.org/10.1148/radiol.13121360
doi: 10.1148/radiol.13121360 pubmed: 23382293
Parente DB, Rodrigues RS, Paiva FF et al (2014) Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice? PLoS One 9:e112574 https://doi.org/10.1371/journal.pone.0112574
doi: 10.1371/journal.pone.0112574 pubmed: 25426708 pmcid: 4245094
Boudinaud C, Abergel A, Joubert-Zakeyh J et al (2019) Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: evaluation of four MR techniques versus biopsy. Eur J Radiol 118:169–174. https://doi.org/10.1016/j.ejrad.2019.07.025
doi: 10.1016/j.ejrad.2019.07.025 pubmed: 31439237
Hwang I, Lee JM, Lee KB et al (2014) Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. Radiology 271:730–738. https://doi.org/10.1148/radiol.14130863
doi: 10.1148/radiol.14130863 pubmed: 24533869
Kühn J-P, Evert M, Friedrich N et al (2011) Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2* relaxation effects. Invest Radiol 46:783–789. https://doi.org/10.1097/RLI.0b013e31822b124c
doi: 10.1097/RLI.0b013e31822b124c pubmed: 21808200
El-Badry AM, Breitenstein S, Jochum W et al (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691–697. https://doi.org/10.1097/SLA.0b013e3181bcd6dd
doi: 10.1097/SLA.0b013e3181bcd6dd pubmed: 19806055
Franzén LE, Ekstedt M, Kechagias S, Bodin L (2005) Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 18:912–916. https://doi.org/10.1038/modpathol.3800370
Rawlins SR, El-Zammar O, Zinkievich JM et al (2010) Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C. Dig Dis Sci 55:2049–2057. https://doi.org/10.1007/s10620-010-1254-x
doi: 10.1007/s10620-010-1254-x pubmed: 20458626
Longo R, Pollesello P, Ricci C et al (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285. https://doi.org/10.1002/jmri.1880050311
doi: 10.1002/jmri.1880050311 pubmed: 7633104
Nasr P, Forsgren MF, Ignatova S et al (2017) Using a 3% proton density fat fraction as a cut-off value increases sensitivity of detection of hepatic steatosis, based on results from histopathology analysis. Gastroenterology 153:53-55.e7. https://doi.org/10.1053/j.gastro.2017.03.005
doi: 10.1053/j.gastro.2017.03.005 pubmed: 28286210
Galimberti S, Trombini P, Bernasconi DP et al (2015) Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia. Scand J Gastroenterol 50:429–438. https://doi.org/10.3109/00365521.2014.940380
doi: 10.3109/00365521.2014.940380 pubmed: 25633726
Cesbron-Métivier E, Roullier V, Boursier J et al (2010) Noninvasive liver steatosis quantification using MRI techniques combined with blood markers. Eur J Gastroenterol Hepatol 22:973–982. https://doi.org/10.1097/meg.0b013e32833775fb
doi: 10.1097/meg.0b013e32833775fb pubmed: 20665947
Jayakumar S, Middleton MS, Lawitz EJ et al (2019) Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. J Hepatol 70:133–141. https://doi.org/10.1016/j.jhep.2018.09.024
doi: 10.1016/j.jhep.2018.09.024 pubmed: 30291868
St Pierre TG, House MJ, Bangma SJ et al (2016) Stereological analysis of liver biopsy histology sections as a reference standard for validating non-invasive liver fat fraction measurements by MRI. PLoS One 11:e0160789 https://doi.org/10.1371/journal.pone.0160789
doi: 10.1371/journal.pone.0160789 pubmed: 27501242 pmcid: 4976876

Auteurs

T Orcel (T)

Department of Radiology, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.

H T Chau (HT)

Department of Radiology, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.
NUMECAN, INSERM U1099, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.

B Turlin (B)

NUMECAN, INSERM U1099, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.
Department of Pathology, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.

J Chaigneau (J)

HIFIH, UPRES EA3859, Angers University Hospital, 4 Rue Larrey, 49993, Angers, France.

E Bannier (E)

Department of Radiology, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.
EMPENN U746 Unit/Project, INSERM/INRIA, IRISA, University of Rennes, Beaulieu Campus, UMR CNRS 6074, 35042, Rennes, France.

P Otal (P)

Department of Radiology, Toulouse University Hospital, 1 Av Pr J. Poulhes, 31059, Toulouse, France.

E Frampas (E)

Department of Radiology, Nantes University Hospital, 1 Pl. Alexis-Ricordeau, 44000, Nantes, France.

A Leguen (A)

Department of Radiology, Bretagne-Atlantique Hospital, 20 Bd Général Maurice Guillaudot, 56000, Vannes, France.

A Boulic (A)

Department of Radiology, Bretagne Sud Hospital, 5 Avenue de Choiseul, 56322, Lorient, France.

H Saint-Jalmes (H)

INSERM U1099, LTSI, University of Rennes, Beaulieu Campus, 35042, Rennes, France.

C Aubé (C)

HIFIH, UPRES EA3859, Angers University Hospital, 4 Rue Larrey, 49993, Angers, France.
Department of Radiology, Angers University Hospital, 4 Rue Larrey, 49993, Angers, France.

J Boursier (J)

HIFIH, UPRES EA3859, Angers University Hospital, 4 Rue Larrey, 49993, Angers, France.
Department of Hepatology-GastoeEnterology, Angers University Hospital, 4 Rue Larrey, 49993, Angers, France.

E Bardou-Jacquet (E)

NUMECAN, INSERM U1099, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.
Department of Hepatology, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France.

Y Gandon (Y)

Department of Radiology, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France. yves.gandon@yahoo.fr.
NUMECAN, INSERM U1099, Rennes University Hospital, 2 Rue H. Le Guilloux, 35033, Rennes, France. yves.gandon@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH